2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
P06.009<br />
A candidate phenotypic modifier gene in fibrinogen deficient<br />
mice: beta-1,4-N-acetyl-galactosaminyl transferase 1 (galgt1)<br />
R. J. Fish 1 , D. Vu 1 , A. Fort 1 , S. Deutsch 1 , J. Degen 2 , M. Neerman-Arbez 1 ;<br />
1 Geneva University Faculty <strong>of</strong> Medicine, Geneva, Switzerland, 2 Cincinnati<br />
Children’s Hospital Research Foundation and University <strong>of</strong> Cincinnati College<br />
<strong>of</strong> Medicine, Cincinnati, OH, United States.<br />
In humans the absence <strong>of</strong> circulating fibrinogen leads to a bleeding disorder<br />
with variable severity, afibrinogenemia. Fibrinogen alpha chain<br />
knock-out mice (FGA-/-) are effectively afibrinogenemic and show a<br />
strain-specific bleeding phenotype in neonates. This variability implies<br />
that modifier genes exist in FGA-/- mice and in humans with afibrinogenemia<br />
. About 70% <strong>of</strong> C57BL/6 FGA-/- mice die in the neonatal period<br />
whereas survivors have normal longevity . Fewer (~20%) FVB/N<br />
FGA-/- mice die as neonates but show high mortality at P30 to P60 . To<br />
identify candidate FGA-/- phenotypic modifier genes, we used microarray<br />
analysis on liver RNA from both mouse strains . Of the genes identified<br />
with variable expression between strains, one encodes a Beta-1,4-<br />
N-acetyl-galactosaminyl transferase (galgt1) . A galgt1 paralog, galgt2,<br />
was identified as a modifier gene in a mouse model <strong>of</strong> another human<br />
bleeding disorder, von Willebrand’s disease(1) . By RT-PCR, we found<br />
that galgt1 expression increases in the liver <strong>of</strong> C57BL/6 mice from P0<br />
to P30 . In contrast, galgt1 expression is low in FVB/N mice at birth and<br />
declines with age. Using strain-specific polymorphisms and sequencing<br />
<strong>of</strong> RT-PCR products, we determined the expression <strong>of</strong> C57BL/6<br />
and FVB/N galgt1 alleles in livers from F1 hybrid mice . Both alleles<br />
were expressed at P0, but only the C57BL/6 allele was detected at<br />
P30 . Using pyrosequencing, the FVB/N allele expression was 22 .8%<br />
at P0 and undetectable at P30 . We are investigating the genetic basis<br />
for this differential allelic expression and whether it can explain strainspecific<br />
phenotypic variation in FGA-/- mice. (1)Mohlke et al, (1999)<br />
Cell, 96, p111-120 .<br />
P06.010<br />
Identification <strong>of</strong> susceptibility genes for Multiple sclerosis: a<br />
study <strong>of</strong> the genomic region 2q13-14 in an italian population<br />
I. Borzani1 , M. Tola1 , L. Caniati2 , G. De Santis1 , A. R. Collins3 , C. Scapoli1 ;<br />
1 2 3 University <strong>of</strong> Ferrara, Ferrara, Italy, St. Anna Hospital, Ferrara, Italy, University<br />
<strong>of</strong> Southampton, Southampton, United Kingdom.<br />
Understanding the genetic basis <strong>of</strong> multiple sclerosis (MS) remains<br />
a major challenge, despite decades <strong>of</strong> intensive researches . Whole<br />
genome linkage studies were carried out in different populations and<br />
from these analyses the prediction <strong>of</strong> at least 38 potential non-MHC<br />
susceptibility regions emerged (Abdeen et al ., 2006) . Among these,<br />
chromosomal portions <strong>of</strong> specific interest to some populations came<br />
out: the region 2q14 in the Irish and English population (Heggarty et<br />
al ., 2003; Mann et al ., 2002), the region 2q36 in the Sardinians (Coraddu<br />
et al, 2003) and the region 2p21-22 in Continental Italian population<br />
(Liguori et al ., 2003) .<br />
The main objective <strong>of</strong> this study was to investigate the role <strong>of</strong> 2q13-14<br />
region in the pathogenesis <strong>of</strong> MS . The investigation was conducted on<br />
120 patients, with clinically defined MS, and on 249 healthy subjects<br />
collected from the North-Italian population . Using CHROMSCAN (Maniatis<br />
et al, 2002, 2005), a map in LD-units, under the Malécot model<br />
for multiple markers, was constructed . The block-step structure <strong>of</strong> the<br />
2q13-14 region was based on 70 SNPs (validated in the Caucasian<br />
population) selected from the HapMap database, with rare variant frequencies<br />
higher than 10% and evenly covering a region <strong>of</strong> 1 .2 Mb<br />
within the segment 2q13-14 .<br />
We tested the association with the disease through both allelic association<br />
and by association mapping with the Malécot Model (Morton<br />
et al . 2007) .<br />
The present results support a possible association between this candidate<br />
region and MS in the North-Italian population .<br />
P06.011<br />
Association between the N-acetyltransferase 2 (NAt2) gene<br />
polymorphisms and allergic rhinitis in Volga-Ural region <strong>of</strong><br />
Russia<br />
A. Khuzina 1 , A. Karunas 1 , A. Biktasheva 2 , A. Yuldasheva 3 , E. Etkina 2 , E. Khusnutdinova<br />
1 ;<br />
1 Institute <strong>of</strong> Biochemistry and <strong>Genetics</strong>, Ufa Scientific Center, Russian Academy<br />
<strong>of</strong> Sciences, Ufa, Russian Federation, 2 Bashkir Medical State University,<br />
Ufa, Russian Federation, 3 Pediatric polyclinic N1, Ufa, Russian Federation.<br />
Allergic rhinitis (AR) is the result <strong>of</strong> an immunologically mediated hypersensitivity<br />
reaction <strong>of</strong> the nasal mucosa, initiated by exposure to<br />
specific allergens. The prevalence <strong>of</strong> AR in various countries ranges<br />
from 10-25% . It has been suggested in various studies that genetic<br />
defects in acetylation may be involved in the pathogenesis <strong>of</strong> allergic<br />
diseases and atopy .<br />
The aim <strong>of</strong> this study was to examined the allele and genotype frequencies<br />
<strong>of</strong> three polymorphisms (481C>T, 590G>A, 857G>A) <strong>of</strong> the<br />
gene and analysed their combinations . The patient group consisted<br />
<strong>of</strong> 264 individuals with AR with different ethnic origins (Russians, Tatars,<br />
Bashkirs), the control group included 185 unrelated non-allergic<br />
individuals . The NAT2 alleles (*4, *5, *6, and *7) were determined by<br />
polymerase chain reaction-restriction fragment length polymorphism<br />
methods with DNA extracted from peripheral blood leucocytes by standard<br />
phenol/chlor<strong>of</strong>orm method .<br />
The analysis has revealed that Tatars have significant higher frequency<br />
<strong>of</strong> *4 allele (wild type) <strong>of</strong> the NAT2 gene in control group than in<br />
patients (P=0,0007; OR=0,34; 95%CI=0,18-0,64) . At comparison <strong>of</strong><br />
group <strong>of</strong> patients with high total IgE level and the control group we<br />
have also determined increased frequency <strong>of</strong> *4 allele <strong>of</strong> the NAT2<br />
gene in healthy donors (P=0,026; OR=0,53; 95%CI=0,3-0,93) . Moreover,<br />
an association <strong>of</strong> *5*6 genotype <strong>of</strong> the NAT2 gene with AR at<br />
patients with high total IgE level has been found (P=0,012; OR=2,4;<br />
95%CI=1,19-4,82) .<br />
Thus, we have determined statistically significant association between<br />
NAT2 gene polymorphisms and allergic rhinitis in Volga-Ural region <strong>of</strong><br />
Russia .<br />
P06.012<br />
inherited alopecia and ectodermal dysplasia in pakistani<br />
kindereds<br />
I. Ahmad, M. Tariq, A. Ali, M. Bakhtiar, A. Azhar, S. M. Baig;<br />
National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad,<br />
Pakistan.<br />
Inherited Alopecia (AP) is a rare autosomal recessive disease clinically<br />
characterized by total or partial hair loss soon after their birth and the<br />
development <strong>of</strong> papular lesions <strong>of</strong> keratin-filled cysts over extensive<br />
area <strong>of</strong> body . The inherited hypohidrotic and anhydrotic ectodermal<br />
dysplasia (ED) is characterized by the absence or hypoplasia <strong>of</strong> hair,<br />
teeth and eccrine sweat gland . Ecotodermal dysplasias are highly heterogeneous<br />
with more than 200 distinct clinical forms reported so far .<br />
The X-linked hypohidrotic ectodermal dysplasia (XLED) is the most<br />
common form <strong>of</strong> ED . In this study, twelve consanguineous families<br />
with alopecia and seven with ectodermal dysplasia were ascertained<br />
from Southern Punjab and Northern areas <strong>of</strong> Pakistan having multiple<br />
affected members . Pedigrees were analyzed to determine the pattern<br />
<strong>of</strong> inheritance; in four families with AP the disease was inherited in the<br />
autosomal recessive pattern . Short Tandem Repeat Markers (STR)<br />
were used in the exclusion mapping for the ten most common loci reported<br />
. According to results, one family with AP was linked to the type<br />
1 keratin genes (17q21 .2locus) while other families are still undergoing<br />
exclusion analysis . In four families with ED exclusion to all known<br />
loci has been observed whereas one family is showing linkage to the<br />
type II keratin (KRT) genes (12q13 .13 locus) . Exclusion analysis is in<br />
process in two pedigrees with ED . The families excluded to all known<br />
loci will be subjected to genome wide scan by SNP (Single Nucleotide<br />
Polymorphism) analysis using Affymetrix 250K array system to find the<br />
homozygous regions to find out the locus having the disease gene.<br />
Statistical analysis such as LOD (log <strong>of</strong> odds) will be used to validate<br />
the data obtained .<br />
P06.013<br />
Alpha-synuclein in familial Parkinson‘s disease and Lewy Body<br />
Dementia<br />
V. Greco 1 , E. De Marco 1 , F. Rocca 1 , P. Tarantino 1 , F. Annesi 1 , D. Civitelli 1 , G.<br />
Provenzano 1 , V. Scornaienchi 1 , I. Cirò Candiano 1 , S. Carrideo 1 , G. Squillace 1 ,<br />
G. Nicoletti 1,2 , G. Annesi 1 ;<br />
1 Institute <strong>of</strong> Neurological Sciences, National Research Council, Mangone<br />
(Cosenza), Italy, 2 Institute <strong>of</strong> Neurology, University Magna Graecia, Catanzaro,<br />
Italy.<br />
Alpha-synuclein has been implicated in the pathology <strong>of</strong> certain neurodegenerative<br />
diseases, including Parkinson’s disease (PD) and de-<br />
0